Kabra Drugs Limited has announced a certificate from its Registrar & Share Transfer Agent, M/s Skyline Financial Services Pvt Ltd, confirming compliance related to its shareholding pattern for the quarter ended June 30, 2025. This attestation ensures the accuracy and proper maintenance of the company's dematerialized share records, supporting transparency and investor confidence in the company’s equity management.